• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病相关蛋白上淀粉样β肽的分泌组学变化在分化的人 SH-SY5Y 神经母细胞瘤细胞中。

Secretomic changes of amyloid beta peptides on Alzheimer's disease related proteins in differentiated human SH-SY5Y neuroblastoma cells.

机构信息

Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand.

Undergraduate Student of Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumtani, Thailand.

出版信息

PeerJ. 2024 Jul 17;12:e17732. doi: 10.7717/peerj.17732. eCollection 2024.

DOI:10.7717/peerj.17732
PMID:39035166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11260076/
Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that causes physical damage to neuronal connections, leading to brain atrophy. This disruption of synaptic connections results in mild to severe cognitive impairments. Unfortunately, no effective treatment is currently known to prevent or reverse the symptoms of AD. The aim of this study was to investigate the effects of three synthetic peptides, i.e., KLVFF, RGKLVFFGR and RIIGL, on an AD model represented by differentiated SH-SY5Y neuroblastoma cells exposed to retinoic acid (RA) and brain-derived neurotrophic factor (BDNF). The results demonstrated that RIIGL peptide had the least significant cytotoxic activity to normal SH-SY5Y while exerting high cytotoxicity against the differentiated cells. The mechanism of RIIGL peptide in the differentiated SH-SY5Y was investigated based on changes in secretory proteins compared to another two peptides. A total of 380 proteins were identified, and five of them were significantly detected after treatment with RIIGL peptide. These secretory proteins were found to be related to microtubule-associated protein tau (MAPT) and amyloid-beta precursor protein (APP). RIIGL peptide acts on differentiated SH-SY5Y by regulating amyloid-beta formation, neuron apoptotic process, ceramide catabolic process, and oxidative phosphorylation and thus has the potentials to treat AD.

摘要

阿尔茨海默病(AD)是一种神经退行性疾病,会导致神经元连接的物理损伤,从而导致大脑萎缩。这种突触连接的破坏导致轻度至重度认知障碍。不幸的是,目前尚无已知的有效治疗方法可以预防或逆转 AD 的症状。本研究旨在研究三种合成肽,即 KLVFF、RGKLVFFGR 和 RIIGL,对分化的 SH-SY5Y 神经母细胞瘤细胞暴露于维甲酸(RA)和脑源性神经营养因子(BDNF)的 AD 模型的影响。结果表明,RIIGL 肽对正常 SH-SY5Y 的细胞毒性作用最小,但对分化细胞的细胞毒性作用最高。与另外两种肽相比,根据分泌蛋白的变化研究了 RIIGL 肽在分化的 SH-SY5Y 中的作用机制。共鉴定出 380 种蛋白质,其中 5 种在 RIIGL 肽处理后明显检测到。这些分泌蛋白与微管相关蛋白 tau(MAPT)和淀粉样前体蛋白(APP)有关。RIIGL 肽通过调节淀粉样β形成、神经元凋亡过程、神经酰胺分解代谢过程、氧化磷酸化作用于分化的 SH-SY5Y,因此具有治疗 AD 的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/c2f504c633a3/peerj-12-17732-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/0a3710e9018b/peerj-12-17732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/a44a48cae076/peerj-12-17732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/9ad184b77b7d/peerj-12-17732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/09549822dd1d/peerj-12-17732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/8165fce1f33f/peerj-12-17732-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/44282796b8bf/peerj-12-17732-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/096331f4f9fd/peerj-12-17732-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/c2f504c633a3/peerj-12-17732-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/0a3710e9018b/peerj-12-17732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/a44a48cae076/peerj-12-17732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/9ad184b77b7d/peerj-12-17732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/09549822dd1d/peerj-12-17732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/8165fce1f33f/peerj-12-17732-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/44282796b8bf/peerj-12-17732-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/096331f4f9fd/peerj-12-17732-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/11260076/c2f504c633a3/peerj-12-17732-g008.jpg

相似文献

1
Secretomic changes of amyloid beta peptides on Alzheimer's disease related proteins in differentiated human SH-SY5Y neuroblastoma cells.阿尔茨海默病相关蛋白上淀粉样β肽的分泌组学变化在分化的人 SH-SY5Y 神经母细胞瘤细胞中。
PeerJ. 2024 Jul 17;12:e17732. doi: 10.7717/peerj.17732. eCollection 2024.
2
The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.视黄酸和脑源性神经营养因子分化的SH-SY5Y细胞系作为阿尔茨海默病样tau蛋白磷酸化的模型。
Biochem Biophys Res Commun. 2004 Jul 2;319(3):993-1000. doi: 10.1016/j.bbrc.2004.05.075.
3
Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer's Disease Studies.人神经母细胞瘤 SH-SY5Y 细胞系的胆碱能分化及其作为阿尔茨海默病研究体外模型的潜在用途。
Mol Neurobiol. 2019 Nov;56(11):7355-7367. doi: 10.1007/s12035-019-1605-3. Epub 2019 Apr 29.
4
Expression and Localization of AβPP in SH-SY5Y Cells Depends on Differentiation State.β淀粉样蛋白前体在 SH-SY5Y 细胞中的表达和定位依赖于分化状态。
J Alzheimers Dis. 2021;82(2):485-491. doi: 10.3233/JAD-201409.
5
Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.新型咔唑类荧光染料 SLM 对 SH-SY5Y 细胞模型和阿尔茨海默病 3xTg-AD 小鼠模型的神经保护作用。
ACS Chem Neurosci. 2017 Mar 15;8(3):676-685. doi: 10.1021/acschemneuro.6b00388. Epub 2016 Dec 29.
6
A Transient Survival Model of Alteration of Electrophysiological Properties Due to Amyloid Beta Toxicity Based on SH-SY5Y Cell Line.基于 SH-SY5Y 细胞系的淀粉样β毒性导致电生理特性改变的瞬时存活模型。
Curr Alzheimer Res. 2020;17(13):1208-1213. doi: 10.2174/1567205018666210212155750.
7
Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.微小 RNA-137 抑制阿尔茨海默病中的 Tau 过度磷酸化,并在转基因小鼠和人神经母细胞瘤 SH-SY5Y 细胞中靶向 CACNA1C 基因。
Med Sci Monit. 2018 Aug 13;24:5635-5644. doi: 10.12659/MSM.908765.
8
Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells.寡聚淀粉样蛋白通过特异性下调分化的人神经母细胞瘤细胞中脑源性神经营养因子(BDNF)转录本IV和V,降低BDNF mRNA的基础水平。
J Neurosci. 2007 Mar 7;27(10):2628-35. doi: 10.1523/JNEUROSCI.5053-06.2007.
9
Toxicity of Amyloid-β Peptides Varies Depending on Differentiation Route of SH-SY5Y Cells.淀粉样β肽的毒性取决于 SH-SY5Y 细胞的分化途径。
J Alzheimers Dis. 2019;71(3):879-887. doi: 10.3233/JAD-190705.
10
Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.长非编码 RNA 00507/miRNA-181c-5p/TTBK1/MAPT 轴调控阿尔茨海默病中 tau 的过度磷酸化。
J Gene Med. 2020 Dec;22(12):e3268. doi: 10.1002/jgm.3268. Epub 2020 Sep 23.

引用本文的文献

1
Effectiveness of co-cultured Myristica fragrans Houtt. seed extracts with commensal Staphylococcus epidermidis and its metabolites in antimicrobial activity and biofilm formation of skin pathogenic bacteria.肉豆蔻种子提取物与共生表皮葡萄球菌及其代谢产物协同培养对皮肤致病菌的抗菌活性和生物膜形成的影响。
BMC Complement Med Ther. 2024 Oct 31;24(1):380. doi: 10.1186/s12906-024-04675-z.

本文引用的文献

1
Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and inhibition of amyloid β peptide aggregation, acetylcholinesterase and carbonic anhydrase-II.用于治疗阿尔茨海默病的孕烯醇酮衍生物:合成以及对淀粉样β肽聚集、乙酰胆碱酯酶和碳酸酐酶-II的抑制作用
RSC Adv. 2024 May 7;14(21):14742-14757. doi: 10.1039/d4ra01536c. eCollection 2024 May 2.
2
Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer's disease.新型9H-咔唑-4H-色烯杂合物作为双重胆碱酯酶抑制剂用于治疗阿尔茨海默病的研发。
Mol Divers. 2025 Feb;29(1):379-396. doi: 10.1007/s11030-024-10859-z. Epub 2024 Apr 29.
3
Synthesis and mechanistic study of ultrashort peptides that inhibits Alzheimer's Aβ-aggregation-induced neurotoxicity.
超短肽的合成及抑制阿尔茨海默病 Aβ 聚集诱导神经毒性的机制研究。
Bioorg Chem. 2024 Mar;144:107159. doi: 10.1016/j.bioorg.2024.107159. Epub 2024 Jan 29.
4
Alzheimer's disease: From immunotherapy to immunoprevention.阿尔茨海默病:从免疫疗法到免疫预防。
Cell. 2023 Sep 28;186(20):4260-4270. doi: 10.1016/j.cell.2023.08.021. Epub 2023 Sep 19.
5
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
6
The incongruity of validating quantitative proteomics using western blots.使用蛋白质免疫印迹法验证定量蛋白质组学的不一致性。
Nat Plants. 2022 Dec;8(12):1320-1321. doi: 10.1038/s41477-022-01314-8.
7
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
8
Metabolic Responses and Pathway Changes of Vero Cells under High-Vitamin B Medium.高维生素B培养基条件下Vero细胞的代谢反应及通路变化
Vaccines (Basel). 2022 Oct 25;10(11):1787. doi: 10.3390/vaccines10111787.
9
The Anti-Aggregative Peptide KLVFF Mimics Aβ1-40 in the Modulation of Nicotinic Receptors: Implications for Peptide-Based Therapy.抗聚集肽KLVFF在烟碱型受体调节中模拟Aβ1-40:对基于肽的治疗的启示。
Biomedicines. 2022 Sep 8;10(9):2231. doi: 10.3390/biomedicines10092231.
10
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.阿杜海姆,一种新型抗淀粉样蛋白单克隆抗体,用于治疗阿尔茨海默病:全面综述。
Health Psychol Res. 2022 Jul 28;10(3):37023. doi: 10.52965/001c.37023. eCollection 2022.